Additionally, no substantial differences between the two groups were found in clinical stage, site of metastasis, treatment modality, family history, treatment response, age, smoking status, pathological type, HP, DM, COPD, PTB, BMI, SBP, DBP, hemoglobin, lymphocyte count, platelet count, HDL-C, Cr, ALT, FBG, AST, TBil, UA, TG, SP, SS, and SII (p > 0.05). This evidence concerns the gene GPT and diabetes mellitus.